Politics & Policy
Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Read more at FOX ›
Read the full story at
FOX
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX, and the link opens their page. This page exists so readers can find, share, and discuss the story here.